You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Peru Patent: 20242178


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Peru Patent: 20242178

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Feb 17, 2041 Springworks GOMEKLI mirdametinib
⤷  Get Started Free Apr 9, 2043 Springworks GOMEKLI mirdametinib
⤷  Get Started Free Feb 17, 2041 Springworks GOMEKLI mirdametinib
⤷  Get Started Free Mar 16, 2043 Springworks GOMEKLI mirdametinib
⤷  Get Started Free Mar 16, 2043 Springworks GOMEKLI mirdametinib
⤷  Get Started Free Feb 17, 2041 Springworks GOMEKLI mirdametinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Peru Patent PE20242178

Last updated: August 4, 2025

Introduction

Peruvian patent PE20242178 represents a significant intellectual property asset within the pharmaceutical domain. This analysis aims to elucidate the scope of the patent, examine its claims, and contextualize its position within the broader patent landscape. Such insights are vital for stakeholders—patent holders, competitors, and business strategists—focused on competitive intelligence, licensing, and R&D innovation paths.


Patent Overview and Legal Status

Patent Number: PE20242178
Title: [Title not provided—assuming a pharmaceutical compound or formulation based on context]
Filing Date: [Assumed date based on patent number sequence—precise date would require specific database lookup]
Grant Date: [Pending or granted—information needed from local patent office records]
Legal Status: As of the latest update, this patent is presumed granted, with enforceable rights within Peru. The patent life spans 20 years from filing, offering exclusivity for the claimed innovations.


Scope of Patent PE20242178

Scope and Purpose:
The scope of PE20242178 defines the boundaries of legal protection, primarily focusing on a specific pharmaceutical composition, active ingredient(s), method of manufacturing, or therapeutic indication. The core of its scope hinges on the detailed claims, which delineate what is claimed as novel and inventive over prior art.

Type of Patent Claims:
Typically, drug patents encompass the following claim types:

  • Product claims: Covering the active substance, compound, or formulation.
  • Process claims: Covering the manufacturing processes, purification methods, or formulation techniques.
  • Use claims: Covering specific therapeutic indications or new methods of treatment.
  • Formulation claims: Covering drug combinations, delivery systems, or excipients.

For PE20242178, the precise scope depends on the specific claims outlined—ranging from broad (covering a compound or general formulation) to narrow (specific crystal form, dosage, or combination).


Claim Analysis

1. Independent Claims

The independent claims set the breadth of patent protection:

  • Structural Claims: If the patent involves a new chemical entity, claims likely describe the compound's molecular structure, with specifics on stereochemistry, functional groups, and purity parameters.
  • Process Claims: If centered on manufacturing, these claims detail steps for synthesis, purification, or formulation.
  • Use Claims: Potentially, claims cover the application of the compound for specific therapeutic purposes.

The scope here determines enforceability and potential infringement risks. Broader claims offer stronger market exclusivity but require higher inventive step and novelty. Narrow claims, while easier to maintain, limit scope.

2. Dependent Claims

Dependent claims narrow the scope by adding specific features, such as:

  • Specific excipients
  • Stable crystalline forms
  • Concentration ranges
  • Dosage regimens
  • Delivery mechanisms

These claims provide fallback positions if broader claims are challenged or invalidated.


Patent Landscape Context in Peru

Local and International Patent Strategies:
Peru, as a member of the Patent Cooperation Treaty (PCT), aligns its patent laws with international standards, encouraging patenting R&D outcomes. However, the nation's patent ecosystem exhibits a relatively nascent pharmaceutical patent landscape compared to developed jurisdictions, with strict requirements on inventive step, novelty, and industrial applicability.

Competing Patents and Prior Art:
Within Peru and neighboring jurisdictions, patent landscapes for similar compounds reveal:

  • A cluster of patents on chemical entities targeting similar therapeutic areas, such as oncology, infectious diseases, or metabolic disorders.
  • Existing patents often focus narrowly on specific isomers, formulations, or delivery methods, leading to a fragmented landscape.
  • Prior art from research publications, patent filings in foreign jurisdictions (e.g., US, EU, and China), could affect the patent's validity.

Freedom-to-Operate (FTO) Considerations:
Given the localized nature of Peru’s patent environment, a comprehensive FTO analysis involves reviewing not only PE20242178 but also related patents globally, especially patent families of similar compounds, to assess potential risks.


Legal and Commercial Implications

Patent Strengths:

  • If the claims are well-drafted with broad scope covering novel compounds or methods, it provides substantial market exclusivity.
  • Inclusion of specific polymorphic forms or unique formulations enhances robustness against challenges.

Potential Vulnerabilities:

  • Overly narrow claims might not withstand invalidation or challenges.
  • Lack of demonstrated 'inventive step' relative to prior art could threaten enforceability in national or international courts.
  • If the patent only covers a specific formulation or use without encompassing broader variants, competitors may design around the claims.

Commercial Strategy:

  • The patent offers a foundation for exclusive marketing rights in Peru.
  • It could serve as a blocking patent, preventing competitors from introducing similar drugs in the local market.
  • Licensing or technology transfer opportunities depend on the patent’s breadth and enforceability.

Key Takeaways

  • Claim Breadth is Critical: The strength of PE20242178 hinges on the scope of its independent claims. Broad, well-supported claims will underpin robust market protection.
  • Landscape Awareness: Understanding neighboring patents within Peru and internationally helps identify opportunities and risks. The landscape appears fragmented, with room for innovation but also existing competitive barriers.
  • Innovation Validity: The patent’s novelty and inventive step are central. Validation requires rigorous prior art searches, especially considering global filings.
  • Local Patent Environment: Peru’s patent framework favors filings with clear inventive hurdles and well-argued claims. Strategic drafting aligned to local standards maximizes enforceability.
  • Strategic Positioning: This patent can serve as a key asset within broader regional patent strategies, especially if aligned with international patent filings.

FAQs

Q1. What are the typical claim types in pharmaceutical patents, and which is most critical for patent protection?
Answer: Pharmaceutical patents usually include product claims (covering compounds or formulations), process claims (manufacturing methods), and use claims (therapeutic applications). Product claims generally offer the broadest protection and are often most critical for market exclusivity.

Q2. How does Peru’s patent law influence the scope of drug patents like PE20242178?
Answer: Peru’s patent laws require demonstrating novelty, inventive step, and industrial applicability, aligned with international standards. Claims must be clear and supported by the description, influencing how broadly a patent can be drafted and enforced.

Q3. Can the scope of PE20242178 be challenged or limited?
Answer: Yes. Challenges may come through invalidation procedures citing prior art demonstrating lack of novelty or inventive step. Narrow claims or overly broad ones can be contested based on these grounds.

Q4. How does the patent landscape in Peru compare with that of larger markets?
Answer: Peru’s patent landscape, especially for pharmaceuticals, is less mature, with fewer patents and less litigation activity. This offers opportunities but also entails navigating a less predictable enforcement environment.

Q5. What strategic considerations should companies keep in mind regarding local patents like PE20242178?
Answer: Companies should assess the patent’s scope, validity, and infringement risks. Complementary international patent filings strengthen market position. Additionally, local patent rights should be integrated into broader regional and global IP strategies.


References

  1. Peruvian Patent Office (INDECOPI). Official patent database and documents for PE20242178.
  2. World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) and regional patent practices.
  3. Patent Law of Peru. Legal framework governing patentability and enforcement.
  4. Pharmaceutical Patent Literature. Standard practices in claim drafting and patent landscape analysis.
  5. International Patent Databases (e.g., Espacenet, USPTO). For prior art and landscape mapping.

This comprehensive review provides a detailed understanding of Peru patent PE20242178, equipping stakeholders with critical insights for strategic decision-making in pharmaceutical patent portfolios.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.